Memphis Daily News Chandler Reports Nashville Ledger
» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Article
VOL. 43 | NO. 24 | Friday, June 14, 2019

Pfizer to buy Array BioPharma in deal worth $11.4 billion

Print | Front Page | Email this story

NEW YORK (AP) — Pfizer is buying the cancer treatment company Array BioPharma in a deal worth $11.4 billion.

Array has a combination therapy for BRAF-mutant metastatic melanoma, along with a pipeline of targeted cancer medicines in development and a portfolio of other medicines that are expected to generate significant royalties over time.

It announced significant advancement in the treatment of colorectal cancer last month.

Array's employees will remain in their current locations, which include Cambridge, Massachusetts, Morrisville, North Carolina, Boulder, Colorado, La Jolla, California and Pearl River, New York.

Pfizer Inc. will pay $48 per share and expects the deal to close in the second half of the year.

Shares of Array BioPharma Inc. surged 60 percent before the opening bell Monday.

Follow us on Facebook, Twitter & RSS:
Sign-Up For Our FREE email edition
Get the news first with our free weekly email
Name
Email  
TNLedger.com Knoxville Editon
RECORD TOTALS DAY WEEK YEAR
PROPERTY SALES 0 0 0
MORTGAGES 0 0 0
FORECLOSURE NOTICES 0 0 0
BUILDING PERMITS 0 0 0
BANKRUPTCIES 0 0 0
BUSINESS LICENSES 0 0 0
UTILITY CONNECTIONS 0 0 0
MARRIAGE LICENSES 0 0 0